On Friday, Solid Biosciences Inc (NASDAQ: SLDB) opened higher 12.50% from the last session, before settling in for the closing price of $5.28. Price fluctuations for SLDB have ranged from $2.41 to $7.37 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 41.25% over the last five years. Company’s average yearly earnings per share was noted 31.67% at the time writing. With a float of $58.88 million, this company’s outstanding shares have now reached $77.88 million.
Solid Biosciences Inc (SLDB) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Solid Biosciences Inc is 24.42%, while institutional ownership is 82.76%. The most recent insider transaction that took place on Dec 03 ’25, was worth 25,203. In this transaction Chief Operating Officer of this company sold 4,932 shares at a rate of $5.11, taking the stock ownership to the 32,908 shares. Before that another transaction happened on Dec 03 ’25, when Company’s President and CEO sold 10,808 for $5.11, making the entire transaction worth $55,229. This insider now owns 81,388 shares in total.
Solid Biosciences Inc (SLDB) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -1 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.78) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.41% during the next five years compared to 41.25% growth over the previous five years of trading.
Solid Biosciences Inc (NASDAQ: SLDB) Trading Performance Indicators
Check out the current performance indicators for Solid Biosciences Inc (SLDB). In the past quarter, the stock posted a quick ratio of 6.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.49, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.04 in one year’s time.
Technical Analysis of Solid Biosciences Inc (SLDB)
Analysing the last 5-days average volume posted by the [Solid Biosciences Inc, SLDB], we can find that recorded value of 1.13 million was lower than the volume posted last year of 1.62 million. As of the previous 9 days, the stock’s Stochastic %D was 32.91%.
During the past 100 days, Solid Biosciences Inc’s (SLDB) raw stochastic average was set at 63.80%, which indicates a significant decrease from 82.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.40 in the past 14 days, which was higher than the 0.40 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.30, while its 200-day Moving Average is $4.91. Now, the first resistance to watch is $6.27. This is followed by the second major resistance level at $6.60. The third major resistance level sits at $7.10. If the price goes on to break the first support level at $5.44, it is likely to go to the next support level at $4.94. Now, if the price goes above the second support level, the third support stands at $4.61.
Solid Biosciences Inc (NASDAQ: SLDB) Key Stats
There are currently 77,910K shares outstanding in the company with a market cap of 462.79 million. Presently, the company’s annual sales total 0 K according to its annual income of -124,700 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -45,780 K.
